Compare TVTX & FBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TVTX | FBNC |
|---|---|---|
| Founded | N/A | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.6B |
| IPO Year | 2013 | 1995 |
| Metric | TVTX | FBNC |
|---|---|---|
| Price | $27.62 | $53.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | $36.25 | ★ $61.25 |
| AVG Volume (30 Days) | ★ 1.1M | 164.2K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.81% |
| EPS Growth | ★ 92.89 | 45.65 |
| EPS | N/A | ★ 2.68 |
| Revenue | N/A | ★ $67,623,000.00 |
| Revenue This Year | $44.62 | $37.82 |
| Revenue Next Year | $32.09 | $2.30 |
| P/E Ratio | ★ N/A | $19.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.91 | $34.50 |
| 52 Week High | $42.13 | $62.64 |
| Indicator | TVTX | FBNC |
|---|---|---|
| Relative Strength Index (RSI) | 41.70 | 32.72 |
| Support Level | $26.72 | $45.57 |
| Resistance Level | $31.47 | $54.37 |
| Average True Range (ATR) | 1.06 | 1.68 |
| MACD | 0.00 | -0.62 |
| Stochastic Oscillator | 32.26 | 7.73 |
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.